Sort
23,748 grants matching “melanoma”
Employing Humanized Microbiome Mice to Understand Immune Activation and Translational Therapeutic Potential in Glioblastoma
$329,317Braden Cox McFarland · University Of Alabama At Birmingham · R01 · FY2025 · CA
MELANOMA VACCINES USING MHC-ASSOCIATED PEPTIDES
$329,300University Of Virginia Charlottesville · R01 · FY2005 · CA
MELANOMA VACCINES USING MHC-ASSOCIATED PEPTIDES
$329,300University Of Virginia Charlottesville · R01 · FY2004 · CA
Increasing Effects of Interferons for Melanoma
$329,300Cleveland Clinic Foundation · R01 · FY2003 · CA
MELANOMA VACCINES USING MHC-ASSOCIATED PEPTIDES
$329,300University Of Virginia Charlottesville · R01 · FY2002 · CA
Increasing Effects of Interferons for Melanoma
$329,300Cleveland Clinic Foundation · R01 · FY2002 · CA
c-Myc Expression during Lymphomagenesis
$329,265M Alanna Ruddell · Fred Hutchinson Cancer Research Center · R01 · FY2006 · CA
Ipilimumab as an adjuvant for HIV vaccines
$329,243Mauricio De Aguiar Martins · University Of Miami School Of Medicine · K01 · FY2017 · OD
Regulation of tissue repair
$329,124Wen-Tien Chen · State University New York Stony Brook · R01 · FY2008 · EB
MELANOMA VACCINES USING MHC-ASSOCIATED PEPTIDES
$329,068University Of Virginia Charlottesville · R01 · FY2003 · CA
PD-1 Abrogation and Immunity in Melanoma
$329,064Jeffrey S Weber · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2010 · CA
Predicting Transcriptional and Epigenetic Networks in Cancer from Sequencing Data
$329,064Jun S Song · University Of Illinois At Urbana-Champaign · R01 · FY2016 · CA
Project 2 Intrathecal Anti-PD-1 Immunotherapy for Metastatic Melanoma Patients with Leptomeningeal Disease (LMD)
$329,063Jennifer A. Wargo · University Of Tx Md Anderson Can Ctr · P50 · FY2020 · CA
Project 1: Personalized Adjuvant Immunotherapy for High-risk Colorectal Cancer.
$329,047Michael J Overman · University Of Tx Md Anderson Can Ctr · P50 · FY2022 · CA
Biology of Melanoma Metastasis
$329,003Meenhard Herlyn · Wistar Institute · R01 · FY2015 · CA
Predicting Transcriptional and Epigenetic Networks in Cancer from Sequencing Data
$328,974Jun S Song · University Of Illinois At Urbana-Champaign · R01 · FY2015 · CA
Combining senescence-inducing and senolytic agents to improve melanoma therapy
$328,942Anna E Vilgelm · Ohio State University · R37 · FY2023 · CA
Project 1: Tumor Cell Intrinsic Determinants of Early Dissemination in Melanoma
$328,933Eva Hernando · New York University School Of Medicine · U54 · FY2022 · CA
Anti-Tumor Autoimmunity by lymphopenia T cell Expansion
$328,921Roberto G Baccala · Scripps Research Institute, The · R01 · FY2008 · CA
Melanoma vaccines using MHC-associated peptides
$328,868Craig Lee Slingluff · University Of Virginia · R01 · FY2011 · CA
Melanoma vaccines using MHC-associated peptides
$328,868Craig Lee Slingluff · University Of Virginia · R01 · FY2012 · CA
Repurposing Clinical ACT Antimalarials for Experimental Melanoma Intervention
$328,815Georg T Wondrak · University Of Arizona · R01 · FY2023 · CA
SEROLOGICAL PROFILING OF MELANOMA PATIENTS AS A DIAGNOSTIC TOOL
$328,812Ruth Halaban · Yale University · P50 · FY2007 · CA
SEROLOGICAL PROFILING OF MELANOMA PATIENTS AS A DIAGNOSTIC TOOL
$328,810Ruth Halaban · Yale University · P50 · FY2010 · CA
SEROLOGICAL PROFILING OF MELANOMA PATIENTS AS A DIAGNOSTIC TOOL
$328,810Ruth Halaban · Yale University · P50 · FY2009 · CA